想了解AI制药怎么从demo变成真工具？听听Chai团队讲Chai-3怎么做到一次性设计治疗级分子，还有CAD式设计套件怎么用。
Chai Discovery联合创始人Matt McPartlon和产品负责人Patil在播客中表示，AI药物设计已从演示阶段进入制药行业信任的工具阶段。Chai-2和Chai-3正推动一次性生成治疗级分子的目标，其CAD式设计套件让科学家精确工程化抗体和结合位点。更快的模型到实验室反馈循环有望将制药的瀑布式发现流程转为迭代循环。他们认为更好的模型、验证、算力和基础设施正将生物学从试错科学转变为工程学科。
Chai Discovery's BioAI Phase Shift: Chai-3, Photoshop for Molecules, One-Shot Drug Design, & Enginee...
Chai Discovery's BioAI Phase Shift: Chai-3, Photoshop for Molecules, One-Shot Drug Design, & Engineering Biology latent.space/p/chai-discove… @chaidiscovery cofounder @Mattmcpartlon1 and product lead @realdealpatil explain why AI drug design has crossed the threshold from impressive demos to pharma-trusted tools, how Chai-2 and Chai-3 are pushing toward one-shot therapeutic-grade molecules, how Chai’s CAD-like design suite lets scientists precisely engineer antibodies and binding sites, why faster model-to-lab feedback loops could turn pharma’s waterfall discovery process into an iterative loop, and how better models, validation, compute, and infrastructure are turning biology from trial-and-error science into an engineering discipline. Your browser does not support the video tag. 🔗 View on Twitter 💬 0 🔄 1 ❤️ 2 👀 291 📊 1 ⚡